Biomarkers of Response to Mepolizumab Treatment in Patients With Nasal Polyps With or Without Bronchial Asthma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Biomarkers of Response to Mepolizumab Treatment in Patients With Nasal Polyps With or Without Bronchial Asthma	Hypersensitivity, Immediate, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Respiratory Hypersensitivity, asthma, bronchial disorder, immune system disorder, lung disorder, nasal cavity polyp, nasal disorder, obstructive lung disease, otorhinolaryngologic disease, polyp, respiratory system disorder	Recruiting	Not stated	2024-03-08		NCT05708300

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Aristotle University Of Thessaloniki	60
Department of Allergy and Clinical Immunology, 424 General Military Training Hospital	1
Department of Otolaryngology, Head and Neck Surgery, Sotiria General Hospital	1
Department of Otorhinolaryngology, Democritus University of Thrace, Alexandroupolis	1
Department of Otorhinolaryngology, Head and Neck Surgery, George Papanikolaou Hospital	1
Department of Pulmonology, Democritus University of Thrace, Alexandroupolis	1
National and Kapodistrian University of Athens	74
Respiratory Medicine Department, University of Ioannina, Faculty of Medicine	1

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Pulmonary Clinic of Aristotle University of Thessaloniki, George Papanikolaou Hospital	Thessaloniki	Greece	1
University Pulmonary Clinic, George Papanikolaou Hospital	Thessaloniki	Greece	1